US Bancorp
- SEC CIK
- 0000036104
- Latest filing
- Aug 12, 2026
CCCC holding history
C4 Therapeutics, Inc. in every 13F filed by US Bancorp, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
CCCC overviewAll 13F holders of CCCCFull Q2 2026 holdings
- Shares (Q3 2025)
- 0
- Sold out in Q3 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 6
- Since Q1 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2025 | 0 | $0 | 0.0% | −11,000−100.0% | Sold out | Holders |
| Q2 2025 | 11,000 | $15.7K | <0.1% | −600−5.2% | Reduced | Holders |
| Q1 2025 | 11,600 | $18.6K | <0.1% | +11,544+20,614.3% | Added | Holders |
| Q4 2024 | 56 | $202 | <0.1% | +18+47.4% | Added | Holders |
| Q3 2024 | 38 | $217 | <0.1% | +38 | New | Holders |
| Q2 2024 | 0 | $0 | 0.0% | −39−100.0% | Sold out | Holders |
| Q1 2024 | 39 | $319 | <0.1% | +39 | New | Holders |
| Q2 2022 | 0 | $0 | 0.0% | −118−100.0% | Sold out | Holders |
| Q1 2022 | 118 | $3.00K | <0.1% | +118 | New | Holders |